Global Liquid Embolics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Liquid Embolics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Liquid Embolics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liquid Embolics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Tumor and Brain Cancer and Brain Arteriovenous Malformations are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Liquid Embolics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Liquid Embolics key manufacturers include Medtronic, Boston Scientific, Abbott, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed and Mizuho America, etc. Medtronic, Boston Scientific, Abbott are top 3 players and held % sales share in total in 2022.
Liquid Embolics can be divided into Isobutyl-2-Cyanoacrylate(IBCA), Ethanol, Sodium Morrhuate and Bletilla Striata, etc. Isobutyl-2-Cyanoacrylate(IBCA) is the mainstream product in the market, accounting for % sales share globally in 2022.
Liquid Embolics is widely used in various fields, such as Tumor and Brain Cancer, Brain Arteriovenous Malformations, Ischemic Stroke and Brain Aneurysm, etc. Tumor and Brain Cancer provides greatest supports to the Liquid Embolics industry development. In 2022, global % sales of Liquid Embolics went into Tumor and Brain Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liquid Embolics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Medtronic
Boston Scientific
Abbott
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Segment by Type
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liquid Embolics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Liquid Embolics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Liquid Embolics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Liquid Embolics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Liquid Embolics introduction, etc. Liquid Embolics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Liquid Embolics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Liquid Embolics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Liquid Embolics key manufacturers include Medtronic, Boston Scientific, Abbott, Cyberonics, Codman & Shurtleff, Stryker, Integra LifeSciences, InoMed and Mizuho America, etc. Medtronic, Boston Scientific, Abbott are top 3 players and held % sales share in total in 2022.
Liquid Embolics can be divided into Isobutyl-2-Cyanoacrylate(IBCA), Ethanol, Sodium Morrhuate and Bletilla Striata, etc. Isobutyl-2-Cyanoacrylate(IBCA) is the mainstream product in the market, accounting for % sales share globally in 2022.
Liquid Embolics is widely used in various fields, such as Tumor and Brain Cancer, Brain Arteriovenous Malformations, Ischemic Stroke and Brain Aneurysm, etc. Tumor and Brain Cancer provides greatest supports to the Liquid Embolics industry development. In 2022, global % sales of Liquid Embolics went into Tumor and Brain Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liquid Embolics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Medtronic
Boston Scientific
Abbott
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Segment by Type
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Segment by Application
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liquid Embolics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Liquid Embolics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Liquid Embolics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Liquid Embolics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Liquid Embolics introduction, etc. Liquid Embolics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Liquid Embolics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.